Publicaciones (63) Publicaciones en las que ha participado algún/a investigador/a

2022

  1. A Simple, Safe, and Effective Method for Preparing Autologous Bio-Based Fibrin Glue for Ophthalmic Use

    Pharmaceutics, Vol. 14, Núm. 11

  2. A method to assess model-based bioequivalence

    Revista Colombiana de Ciencias Químico-Farmacéuticas, Vol. 51, Núm. 3, pp. 1578-1579

  3. A systematic review of drug allergy alert systems

    International Journal of Medical Informatics, Vol. 159

  4. Allergic Adverse Drug Events after Alert Overrides in Hospitalized Patients

    Journal of Patient Safety, Vol. 18, Núm. 6, pp. 630-636

  5. Anticholinesterase Activity of Selected Medicinal Plants from Navarra Region of Spain and a Detailed Phytochemical Investigation of Origanum vulgare L. ssp. vulgare

    Molecules, Vol. 27, Núm. 20

  6. Brain Metabolic Alterations in Alzheimer’s Disease

    International Journal of Molecular Sciences, Vol. 23, Núm. 7

  7. Comparison of two pharmacokinetic–pharmacodynamic models of rocuronium bromide during profound neuromuscular block: analysis of estimated and measured post-tetanic count effect

    British Journal of Anaesthesia, Vol. 128, Núm. 3, pp. 473-481

  8. Design, synthesis and anticancer evaluation of novel Se-NSAID hybrid molecules: Identification of a Se-indomethacin analog as a potential therapeutic for breast cancer

    European Journal of Medicinal Chemistry, Vol. 244

  9. Development of an injectable alginate-collagen hydrogel for cardiac delivery of extracellular vesicles

    International Journal of Pharmaceutics, Vol. 629

  10. Do cytotoxicity and cell death cause false positive results in the in vitro comet assay?

    Mutation Research - Genetic Toxicology and Environmental Mutagenesis, Vol. 881

  11. Dysbiosis and Alzheimer’s Disease: Cause or Treatment Opportunity?

    Cellular and Molecular Neurobiology, Vol. 42, Núm. 2, pp. 377-387

  12. Effect of topical berberine in murine cutaneous leishmaniasis lesions

    Journal of Antimicrobial Chemotherapy, Vol. 77, Núm. 4, pp. 1072-1081

  13. Encapsulation of MSCs and GDNF in an Injectable Nanoreinforced Supramolecular Hydrogel for Brain Tissue Engineering

    Biomacromolecules, Vol. 23, Núm. 11, pp. 4629-4644

  14. Enhanced Gene Delivery Triggered by Dual pH/Redox Responsive Host-Guest Dimerization of Cyclooligosaccharide Star Polycations

    Macromolecular Rapid Communications, Vol. 43, Núm. 11

  15. Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease

    Bioorganic and Medicinal Chemistry, Vol. 58

  16. Genotoxicity of 12 Mycotoxins by the SOS/umu Test: Comparison of Liver and Kidney S9 Fraction

    Toxins, Vol. 14, Núm. 6

  17. Genotoxicity of Graphene-Based Materials

    Nanomaterials, Vol. 12, Núm. 11

  18. Hydrogels for brain repair: application to Parkinson’s disease

    Expert Opinion on Drug Delivery, Vol. 19, Núm. 11, pp. 1521-1537

  19. IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET)

    Trials, Vol. 23, Núm. 1

  20. IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity

    Trials, Vol. 23, Núm. 1